MiR-146a Rs2910164 Polymorphism and Head and Neck Carcinoma Risk: a Meta-analysis Based on 10 Case-control Studies

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Dec 1

PMID 27901485

Citations 5

Authors

Zhaolan Xiang

Jue Song

Xianlu Zhuo

Qi Li

Xueyuan Zhang

Affiliations

Soon will be listed here.

Abstract

Two recent meta-analyses have been conducted on the relationship between miR-146a polymorphism (rs2910164) and head and neck cancer (HNC) risk. However, they have yielded conflicting results. Hence, the aim of the present study was to conduct a quantitative updated meta-analysis addressing this subject. Eligible studies up to Sep 2016 were retrieved and screened from the bio-databases and then essential data were extracted for data analysis. Next, subgroup analyses on ethnicity, source of controls, sample size, and genotyping method were also carried out. As a result, a total of 9 publications involving 10 independent case-control studies were included. The overall data indicated a significant association between miR-146a rs2910164 polymorphism and HNC risk [C vs. G: odds ratio (OR) = 1.14; 95% confidence interval (CI) = 1.00-1.31; CC+CG vs. GG: OR=1.21; 95%CI=1.02-1.43]. Variant alleles of miR-146a rs2910164 may have a correlation with increased HNC risk. Future well-designed studies containing large sample sizes are needed to verify this result.

Citing Articles

The Role of Single Nucleotide Polymorphisms in MicroRNA Genes in Head and Neck Squamous Cell Carcinomas: Susceptibility and Prognosis.

Szmida E, Butkiewicz D, Karpinski P, Rutkowski T, Oczko-Wojciechowska M, Sasiadek M Genes (Basel). 2024; 15(9).

PMID: 39336817 PMC: 11431317. DOI: 10.3390/genes15091226.

Epidemiological, Clinical, and Genomic Profile in Head and Neck Cancer Patients and Their Families.

Chulam T, Bernardi Bertonha F, Villacis R, Goncalves Filho J, Kowalski L, Rogatto S Biomedicines. 2022; 10(12).

PMID: 36552033 PMC: 9775590. DOI: 10.3390/biomedicines10123278.

Analysis of Rare Alleles of and as a Prognostic Marker in Thyroid Cancer in Pakistani Population.

Khan R, Abbasi S, Mansoor Q, Ahmed M, Mir K, Baig R Diagnostics (Basel). 2022; 12(10).

PMID: 36292185 PMC: 9600261. DOI: 10.3390/diagnostics12102495.

Association between miR-146a rs2910164 polymorphism and specific cancer susceptibility: an updated meta-analysis.

Hao X, Xia L, Qu R, Yang X, Jiang M, Zhou B Fam Cancer. 2017; 17(3):459-468.

PMID: 29127520 DOI: 10.1007/s10689-017-0056-0.

Association between a miRNA-146a polymorphism and susceptibility to head and neck squamous cell carcinoma in Chinese patients: A meta-analysis of 8 case-control studies.

Zhang S, Hu F, Liang H, Liu Y, Yang J, Zhou W PLoS One. 2017; 12(10):e0186609.

PMID: 29049342 PMC: 5648221. DOI: 10.1371/journal.pone.0186609.

References

Miao L, Wang L, Zhu L, Du J, Zhu X, Niu Y . Association of microRNA polymorphisms with the risk of head and neck squamous cell carcinoma in a Chinese population: a case-control study. Chin J Cancer. 2016; 35(1):77. PMC: 4981983. DOI: 10.1186/s40880-016-0136-9. View

Park D, Jeon H, Lee S, Choi Y, Lee H, Yoon S . MicroRNA-146a inhibits epithelial mesenchymal transition in non-small cell lung cancer by targeting insulin receptor substrate 2. Int J Oncol. 2015; 47(4):1545-53. DOI: 10.3892/ijo.2015.3111. View

Chu Y, Tzeng S, Lin C, Chien M, Chen M, Yang S . Impacts of microRNA gene polymorphisms on the susceptibility of environmental factors leading to carcinogenesis in oral cancer. PLoS One. 2012; 7(6):e39777. PMC: 3386241. DOI: 10.1371/journal.pone.0039777. View

Labbaye C, Testa U . The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer. J Hematol Oncol. 2012; 5:13. PMC: 3342163. DOI: 10.1186/1756-8722-5-13. View

Lerner C, Wemmert S, Bochen F, Kulas P, Linxweiler M, Hasenfus A . Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration. J Cancer Res Clin Oncol. 2015; 142(4):757-66. DOI: 10.1007/s00432-015-2087-y. View

Hung P, Chang K, Kao S, Chu T, Liu C, Lin S . Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression. Oral Oncol. 2011; 48(5):404-8. DOI: 10.1016/j.oraloncology.2011.11.019. View

Chen X, Zhou T, Chen M, Li N, Liu F . Association of the miRNA146a rs2910164 C>G Polymorphism with Head and Neck Cancer Risk: A Meta-analysis. Asian Pac J Cancer Prev. 2015; 16(9):3871-4. DOI: 10.7314/apjcp.2015.16.9.3871. View

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

Kumaraswamy E, Wendt K, Augustine L, Stecklein S, Sibala E, Li D . BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function. Oncogene. 2014; 34(33):4333-46. PMC: 4739738. DOI: 10.1038/onc.2014.363. View

10.

Irani S . miRNAs Signature in Head and Neck Squamous Cell Carcinoma Metastasis: A Literature Review. J Dent (Shiraz). 2016; 17(2):71-83. PMC: 4885676. View

11.

Vamadeva S, Tadros A . Head and neck reconstruction. Br J Hosp Med (Lond). 2016; 77(6):343-8. DOI: 10.12968/hmed.2016.77.6.343. View

12.

Saba R, Sorensen D, Booth S . MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response. Front Immunol. 2014; 5:578. PMC: 4240164. DOI: 10.3389/fimmu.2014.00578. View

13.

Koshizuka K, Hanazawa T, Fukumoto I, Kikkawa N, Okamoto Y, Seki N . The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma. J Hum Genet. 2016; 62(1):3-13. DOI: 10.1038/jhg.2016.105. View

14.

Dahiya K, Dhankhar R . Updated overview of current biomarkers in head and neck carcinoma. World J Methodol. 2016; 6(1):77-86. PMC: 4804254. DOI: 10.5662/wjm.v6.i1.77. View

15.

Niu Y, Du X, Lu M, Xu Q, Luo J, Shen M . Significant association between functional microRNA polymorphisms and head and neck cancer susceptibility: a comprehensive meta-analysis. Sci Rep. 2015; 5:12972. PMC: 4538372. DOI: 10.1038/srep12972. View

16.

Vrijens K, Bollati V, Nawrot T . MicroRNAs as potential signatures of environmental exposure or effect: a systematic review. Environ Health Perspect. 2015; 123(5):399-411. PMC: 4421768. DOI: 10.1289/ehp.1408459. View

17.

Lung R, Wang X, Tong J, Chau S, Lau K, Cheng S . A single nucleotide polymorphism in microRNA-146a is associated with the risk for nasopharyngeal carcinoma. Mol Carcinog. 2012; 52 Suppl 1:E28-38. DOI: 10.1002/mc.21937. View

18.

Puram S, Rocco J . Molecular Aspects of Head and Neck Cancer Therapy. Hematol Oncol Clin North Am. 2015; 29(6):971-92. PMC: 4648693. DOI: 10.1016/j.hoc.2015.07.003. View

19.

Palmieri A, Carinci F, Martinelli M, Pezzetti F, Girardi A, Cura F . Role of the MIR146A polymorphism in the origin and progression of oral squamous cell carcinoma. Eur J Oral Sci. 2014; 122(3):198-201. DOI: 10.1111/eos.12121. View

20.

Liu Z, Li G, Wei S, Niu J, El-Naggar A, Sturgis E . Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer. 2010; 116(20):4753-60. PMC: 3030480. DOI: 10.1002/cncr.25323. View